Date of management change: February 02, 2012
Port Hueneme, CA-based Stellar Biotechnologies has announced the resignation of Daniel E. Morse as Chief Technology Officer.
Stellar Biotechnologies is a world leader in the development and manufacture of keyhole limpet hemocyanin (KLH).
Daniel E. Morse previously held various technology roles in the biotech industry.
News
Short ProfileName: Daniel Morse
Title: Chief Technology Officer
Company: Stellar Biotechnologies
Industry: Biotechnology
Current Contact InfoEmail: ******@stellarbiotech.com
Phone:.***.***.*14*
To get full contact details, please sign in or
Other IT executives who recently changed jobs as well: Drexel Michael, Lipsey Trevis, Kohavi Lior, Rhodes Andy, Lawrence Alex, Jones Quinn, Rose Anthony, Fuselier Mark, Czajkowski Thomas, Schmidt Sara, Hahn Jonathan
You can find the full directory of IT executives here.
How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.
